PSEN1

PSEN1. The PSEN1 gene encodes the catalytic subunit of the Gamma-secretase complex, an intramembrane Protease essential for processing numerous Transmembrane protein substrates. Its most critical role is in the sequential cleavage of the Amyloid precursor protein, a process central to the generation of Amyloid beta peptides implicated in Alzheimer's disease. Pathogenic variants in this gene represent the most common cause of early-onset, autosomal dominant Familial Alzheimer's disease, making it a focal point for Neuroscience research and therapeutic development.

Gene and protein structure

The PSEN1 gene is located on the long arm of Chromosome 14 and consists of multiple Exons that undergo complex Alternative splicing. The encoded protein, Presenilin 1, is a multi-pass Transmembrane protein predominantly localized to the Endoplasmic reticulum and Golgi apparatus. It undergoes constitutive Endoproteolysis to form a stable, heterodimeric complex comprising an N-terminal fragment and a C-terminal fragment, which is the active form incorporated into the larger Gamma-secretase complex alongside other essential subunits like Nicastrin, APH-1, and PEN-2.

Function and mechanism

As the catalytic core of the Gamma-secretase complex, Presenilin 1 performs regulated intramembrane proteolysis on over 90 known Type I transmembrane protein substrates. Its most extensively studied activity is the sequential cleavage of the Amyloid precursor protein following initial processing by Beta-secretase 1. This activity occurs within the hydrophobic environment of the Cell membrane and is critical for generating Amyloid beta peptides of varying lengths, including the more aggregation-prone Aβ42. Beyond its role in Amyloidogenesis, the complex is vital for cleaving other key signaling molecules, such as Notch receptor, which is fundamental for Cell differentiation and Embryonic development.

Clinical significance

Pathogenic mutations in the PSEN1 gene are the most frequent genetic cause of early-onset Familial Alzheimer's disease, often with onset before age 65 and exhibiting complete Penetrance. These mutations lead to a dominant gain-of-function alteration in Gamma-secretase activity, directly driving Amyloid beta pathology. The clinical phenotype is typically a progressive Dementia characterized by severe Memory impairment, Cognitive decline, and often prominent Myoclonus or Seizure activity. Beyond Alzheimer's disease, certain variants have been associated with other neurodegenerative conditions, including Frontotemporal dementia and Dementia with Lewy bodies, highlighting its broad influence on Proteinopathy.

Mutations and associated diseases

Over 300 pathogenic mutations have been identified in PSEN1, spanning Missense mutation, Nonsense mutation, and Splice site mutation types, with most clustered in the Transmembrane domain regions. These mutations alter the enzymatic activity of the Gamma-secretase complex, most commonly increasing the production ratio of the pathogenic Aβ42 peptide over shorter forms. This biochemical shift initiates Amyloid plaque formation, Neuroinflammation, and subsequent Tauopathy. Specific mutations, such as the A79V substitution, can present with atypical features like Spastic paraparesis, while others are linked to Cerebral amyloid angiopathy.

Research and therapeutic approaches

Research on PSEN1 has been pivotal in validating the Amyloid hypothesis of Alzheimer's disease and has driven the development of targeted therapies. Major strategies have included Gamma-secretase inhibitor compounds, such as those investigated by Eli Lilly and Company and Roche, though early trials faced challenges with mechanism-based toxicity, particularly inhibition of Notch signaling. Current approaches are more selective, including Gamma-secretase modulators designed to shift Amyloid beta production without blocking essential substrate processing. Furthermore, Induced pluripotent stem cell models derived from patients with PSEN1 mutations are invaluable tools for Drug screening and studying disease mechanisms in Neurons and Glia.

Category:Genes on human chromosome 14 Category:Alzheimer's disease